FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

704259004: Ramucirumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3011387018 Ramucirumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3011432018 Ramucirumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
49451000195114 ramucirumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
837471000172116 ramucirumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63601000195118 Ramucirumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ramucirumab Is a agent d'anticorps monoclonal false Inferred relationship Some
Ramucirumab Is a Monoclonal antibody true Inferred relationship Some
Ramucirumab This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vascular endothelial growth factor receptor antagonist (disposition) true Inferred relationship Some
Ramucirumab Is a Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) true Inferred relationship Some
Ramucirumab Is a Antineoplastic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ramucirumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ramucirumab Inferred relationship Some 1
Ramucirumab 10mg/mL solution for intravenous infusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ramucirumab Inferred relationship Some
Ramucirumab 10mg/mL conventional release solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ramucirumab Inferred relationship Some
Product containing only ramucirumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ramucirumab Inferred relationship Some 1
Ramucirumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ramucirumab Inferred relationship Some 1
Product containing only ramucirumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ramucirumab Inferred relationship Some 1
Ramucirumab 10 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ramucirumab Inferred relationship Some 1
Ramucirumab 10 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ramucirumab Inferred relationship Some 1

This concept is not in any reference sets

Back to Start